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Comorbidity research in psychiatric epidemiology mostly uses measures of 
association like odds or risk ratios to express how strongly disorders are linked. In 
contrast, chronic disease epidemiologists increasingly use measures of clustering, 
like multimorbidity (cluster) coefficients, to study comorbidity. This article 
compares measures of association and clustering.  
Methods  
Narrative review, algebraical examples, a secondary analysis of an existing 
dataset and a pooled analysis of published data.  
Results 
Odds and risk ratios, but the former more than the latter, confound clustering with 
coincidental comorbidity. Multimorbidity coefficients provide a pure estimate of 
clustering which is the proportion of the association between disorders that is of 
etiological interest. Odds and risk ratios can express comorbidity between no 
more than two disorders, whilst clustering coefficients, although computationally 
laboursome, can capture multimorbidity of any number of disorders. Cluster 
coefficients depend less on the prevalence of illness in study groups than 
measures of association.  
Conclusion  
Odds and risk ratios are well suited for comorbidity research which focuses on 
which sets of disorders or syndromes tend to occur in combination and the 
implications of this for, for instance, nosological classification, a traditional 
interest of psychiatric epidemiology. However, the cluster coefficient is to be 
preferred if the interest is more aetiological, addressing for example why certain 







The term comorbidity was introduced in 1970 by Feinstein.1 His interest was the 
prognosis of chronic somatic disease and he defined comorbidity as the 
occurrence of other medical conditions additional to an index disease.1 From the 
mid-1980s onward comorbid occurrence of disorders also, and increasingly, 
aroused the interest of psychiatrists. The first psychiatric publication on 
comorbidity appeared in 19852, 15 years after Feinstein introduced the term. 
Psychiatrists’ interest in the phenomenon was probably sparked off by the 
publication, in 1980, of the third edition of the Diagnostic and Statistic Manual of 
Mental Disorders. This expanded the number of psychiatric diagnoses from 158 
in the previous edition to 226, thus also increasing the potential for overlap 
between disorders.3 The trend toward ever more fine-grained classification has 
not halted yet and, in its wake, the explosion of psychiatric research papers on 
comorbidity continues (Fig. 7.1).  
The classification of psychiatric morbidity is less fixed than that of 
somatic disorders. When diagnostic categories are found to be strongly associated, 
diagnostic systems may come in for revision as a result. Indeed, the strength of 
associations between sets of diagnoses is the subject of most publications on 
psychiatric comorbidity and the implications of comorbidity for disease 
classification have occupied psychiatric epidemiologists more than its effects on 
prognosis.5 In this search for associations, the fact that a substantial part of the 
epidemiological overlap between disorders is statistically inevitable is easily 
overlooked. This paper examines the dependence of comorbidity on background 




Definition and classification 
 
Joint occurrence of disorders has been defined in a number of ways, according to 
the number of conditions considered, their degree of overlap in time, and the 
mechanisms responsible. 
 
Fig. 7.1 Classificatory progress (DSM) and absolute and proportionate number of 












Comorbidity versus multimorbidity 
 
As indicated, the term comorbidity was originally used to indicate that a certain 
index disorder is accompanied by one or more other conditions.1 This definition 
implies that the main interest is on the index condition and the effects other 
conditions may have, for instance on its prognosis. More recently, the term 
multimorbidity has been introduced in chronic disease epidemiology to refer to 
any co-occurrence of two but often more than two medical conditions within a 
person.5 The introduction of this term indicates a shift of interest from a given 
index condition to the individuals who suffer multiple disorders. It is gaining wide 
acceptance in the somatic literature but has appeared no more than ten times in 
psychiatric research publications to date. Still, many aspects of psychiatric 
research on comorbidity actually concern multimorbidity: over 14% of 
respondents in the US National Comorbidity Survey had a lifetime history of 
three or more different psychiatric disorders.6
 
 
Episode versus lifetime comorbidity 
 
Feinstein’s original comorbidity concept1 referred to what is now known as 
episode comorbidity (the occurrence of more than one disorder within the same 
person in a specific time span7). The time span mostly refers to a period of 1–12 
months. It has been contrasted with lifetime comorbidity (the occurrence of more 
than one disorder in a person’s whole life7) but it should be noted that the 
distinction between the two is relative since, when episodes are prolonged, they 
may eventually cover entire biographies. Psychiatric episode comorbidity is 
reported on more frequently than lifetime comorbidity. This may be because valid 
lifetime data are harder to come by, but also because, for those who have the 
refinement of diagnostic classifications in mind,more information can be gleaned 
from disorders which overlap in time than from the life-history of individuals who 
suffered multiple disorders over time but never simultaneously. As in the 




of disorders in short periods rather than in persons indicates that psychiatry’s 





Disorders may co-occur through bias, coincidence or because substantive 
associations exist between them. 
 
Bias 
The best-known example of this is Berkson’s bias, referring to the concentration 
of comorbid cases among hospital- treated patients.8 Overreporting or increased 
self-scrutiny may lead to inflated estimates of comorbidity associated with certain 
conditions like depression.9 A special type of classification bias arises when 
diagnostic boundaries are imposed where none exist.4
 
Coincidental comorbidity 
Even when disorders are completely independent of one another, in any study 
population, they can be expected to co-occur at a rate which equals the product of 
the prevalences of the separate conditions.9 Thus, comorbidity rates will be higher 
in “sicker” populations. This proportion of comorbidity which is to be expected 
statistically, has been referred to as coincidental5 or independent.10 We will use 
the former term. 
 
Substantive associations 
When comorbidity rates exceed those which are statistically expected 
(coincidental) and bias has been excluded, there must be substantive associations 
between the disorders involved. This proportion of comorbidity has been referred 
to as cluster11 (the term we will use), dependent10 or associative.5 A lot has been 
written about how and why disorders may occur in combination more often than 
expected12 but, essentially, either of two processes, alone or in combination, must 
operate; the disorders involved share risk factors or the disorders act, directly or 




Quantifying cluster comorbidity and multimorbidity 
 
The risk or rate ratio is the preferred measure of association in psychiatric 
epidemiology and odds ratios are used as an approximation in case control 
designs. The popularity of the odds ratio is principally due to the ease of its 
calculation (being simply the cross-product from a two-by-two table) and to the 
fact that it provides a good estimate of the relative risk, although when disorders 
are more prevalent its value becomes progressively larger than that of the risk 
ratio13 (Fig. 7.2). All major reports on psychiatric comorbidity, like those arising 
from the National Comorbidity Survey6, the OPCS Survey of Psychiatric 
Morbidity14, the Dutch NEMESIS study15 and others, quantify comorbidity with 
odds ratios. However, odds and risk ratios merely express how strongly two 
diagnoses or disorders are associated and are ill suited for the study of cluster 
comorbidity and of multimorbidity. 
 
 
Separating coincidental from cluster comorbidity 
 
Odds and risk ratios estimate the overall strength of association between disorders 
but fail to separate cluster from coincidental comorbidity. The numerical example 
in Fig. 7.2 of a cohort of 10,000 persons of whom 10% have disorder A and 
17.5% disorder B, illustrates this. When comorbidity is merely coincidental, 
odds/risk ratios as well as cluster coefficients are all equal to one, indicating that 
the disorders are not associated and do not cluster. However, when clustering does 
occur, the value of the cluster coefficient, which divides the observed rate of 
comorbidity by the rate which is expected under the nullhypothesis of no 
substantive associations between the separate disorders, is smaller than the values 








Fig. 7.2 Risk ratios, odds ratios and cluster coefficients; divergence in case of 





Coincidental comorbidity only 
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RR = (175*8250) / (825*1750) = 1 RR = (350*8250) / (650*1750) = 2.54 
OR = (175*7425) / (1575*825) = 1 OR = (350*7600) / (1400*650) = 2.92 
CC = 10000*175 / [(175+825)*(175+1575)] = 1 CC = 10000*350 / [(350+650)*(350+1400)] = 2 
 
Risk ratio (RR) 
= 
a/(a+c) 
Odds ratio (OR) 
= 
a*d 





=       a/N 
b/(b+d) b*c expected comorbidity rate [(a+c) / N]*[(a+b) / N] 




URare disease assumption; 
When disease is rare b+d ≈ d 









This disjunction arises because the latter two statistics do not adjust overall 
associations for coincidental comorbidity. Fig. 7.3 illustrates this phenomenon 
indicating that odds and risk ratios (and the former more than the latter,due to 
violation of the rare disease assumption P13P), are always, except in the situation of 
no association, farther away from unity than multimorbidity coefficients and 
increasingly so as clustering (or its reverse: antagonism) between disorders grows 
more pronounced. A similar phenomenon arises when the prevalence of the 
separate disorders in the study population rises. Fig. 7.4 plots risk ratios against 
cluster coefficients at varying rates of the separate conditions (for simplicity’s 
sake the separate conditions are assumed to occur at equal prevalences). It 
illustrates that the cluster coefficient is always nearer to unity (no substantive 
link) than the risk ratio [and, thus, also the odds ratio which deviates more from 
unity than the risk ratio (Fig. 7.3)]. 
The fact that measures of association diverge increasingly from cluster 
coefficients when clustering increases and when the prevalence of morbidity rises 
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Fig. 7.4 Relation between risk ration and cluster coefficient for the joint 




Combinations of multiple disorders 
 
Joint occurrence, in persons or episodes, of more than two psychiatric disorders is 
no exception6 but odds and risk ratios can manage associations between two 
categorical outcomes only. By contrast, the cluster coefficient can be calculated 
for any number of disorders, merely by dividing observed and expected numbers 
of cases. In this case it is sometimes referred to as the multimorbidity coefficient. 
Calculation of the expected rates is computationally laboursome given the large 
number of combinations to be considered when more disorders than just two or 
three are studied. For instance, to calculate the rate at which, in a study of eight 
diagnoses each with different prevalences, any three of these diagnoses can be 
expected to co-occur, 56 separate probabilities have to be added.16*  
 
*When n disorders are considered with individually different prevalences p1, p2 . . . pn 
and one wishes to know the rate at which k of these can be expected to occur together,one 
calculates the expected rate of [(n!/k!*(n-k)!] different combinations. The expected 
probability of each individual combination is given by the product of the probabilities (p) 
of the k disorders which do occur multiplied by the product of the probabilities of non-




Table 7.1 illustrates how the cluster coefficient can summarize evidence of 
multimorbidity using data on month prevalences of six neurotic disorders and 
year prevalences of psychotic disorders and alcohol/substance dependence in 
9,830 adult (16–65 years) participants of the UK OPCS psychiatric morbidity 
survey17.  
 
Table 7.1 Multimorbidity in the OPCS psychiatric morbidity survey17. 
Distribution of 2,653 psychiatric disorders (eight types) over a general population 
sample (16–65 years) 
One-month prevalences: 
Any phobia 2%, Depression 2.7%, OCD 1.8%, Generalized anxiety 4.9%, 
Mixed anxiety-depression 8.2%, Panic disorder 1% 
Year prevalences: 
Schizophrenia 0.5%, Substance and/or alcohol dependence 5.9% 
 
Multimorbidity Observed Expected Multimorbidity coefficientsa
(95% confidence interval) 
0 disorders 7837 7448.7         1.04 (1.02 – 1.06) 
1 disorders 1681 2124.0         0.79 (0.75 – 0.83) 
2 disorders 299 148.7         2.01 (1.79 – 2.25) 
3 disorders 84       3.55       23.63 (18.85 – 29.26) 
4 disorders 23       0.04     532.25 (337.48 – 798.62)  
5 disorders 6           0.0004 16306.68 (5984.33 – 35489.66) 
aAll multimorbidity coefficients are significantly different from 1 (p < 0.050) 
 
Multimorbidity occurs more frequently than expected and this obtains in 
particular for combinations of more disorders than two or three only. On the other 
hand, fewer persons than expected have one diagnosis only. This pattern applies 
in other surveys as well and is independent of which type of disorder is 
considered9. It suggests that, in cases of multimorbidity, the interest should focus 
on which types of individuals are prone to multimorbidity rather than on the exact 





 The context-dependence of cluster comorbidity 
 
It has been demonstrated that overall associations between disorders, as measured 
by odds and risk ratios, increase in strength in “sicker” populations. The 
multimorbidity coefficient corrects for this phenomenon in as far as it is 
attributable to coincidental (expected) cooccurrence of disorders. However, even 
cluster comorbidity may vary between study populations for reasons other than 
merely distributional ones. Effects of disorders on one another may be modified 
by social context. For instance, links between cocaine or alcohol misuse and 
affective disorder are weaker in periods or places where such substance use 
indicates less deviance, i.e. is more normative.18,20 This context-dependence of 
cluster comorbidity will be demonstrated using published data on the link 
between alcohol dependence and depression. 
 
 
Alcohol dependence and affective disorder –context-dependence of the link 
 
Relevant literature was collected by performing a computer- based search of 
literature (EMBASE 1989–February 2000; MEDLINE 1987–April 2000; and 
PSYCHLIT 1987–March 2000) published, with the descriptors alcohol, 
depression, substance use and/or psychiatric comorbidity in their title. As a 
second step, all references given in the selected publications were screened. 
Studies, in any language, which reported numerical data allowing calculation of 
odds/risk ratios and cluster coefficients were included. For each of these, 
information is needed on the prevalence of the separate conditions and either the 
rate of the comorbid condition or at least one measure of association or clustering. 
Further, only studies with diagnoses based on DSMIIIr (APA 1987) or DSMIV 
(APA 1994) were included, because DSMIIIr modified criteria for alcohol 
dependence and misuse. Only comorbidity over a period of 12 months was 
analysed. Twenty-eight studies appeared suitable at first glance but nine articles 







Table 7.2 Comorbidity and clustering between alcohol dependence and major 
depression 










N = 2393 
Population sample  
18 years and older 
2.51 
(1.27 - 4.93) 
2.33 
(1.09 – 4.44) 
2.22 
(1.07 – 4.10) 
Nemesis15
N = 7076 
Population sample  
18 – 65 years  
1.80 
(1.32 – 2.46) 
1.71 
(1.25 – 2.30) 
1.63 




N = 10108 
Population sample  
16 – 64 years 
4.56 
(2.65 – 7.83) 
3.94 
(2.23 – 6.47) 
3.84 
(2.19 – 6.23) 
Speer and 
Bates29
N = 128 
Psychiatric patients  
54 years and older 
3.22 
(1.40 – 7.40) 
2.41 
(1.10 – 5.58) 
1.50 
(0.94 – 2.38) 
Neighbors et 
al.30
N = 112 
Juvenile delinquents 
12 – 28 years 
1.46 
(0.67 – 3.18) 
1.22 
(0.66 – 2.19) 
1.13 
(0.69 – 1.75) 
Henriksson et 
al.31
N = 229 
Suicide victims  
10 – 89 years 
0.41 
(0.27 – 0.75) 
0.58 
(0.33 – 0.96) 
0.67 
(0.39 – 1.00) 
Sherbourne et 
al.32
N = 2296 
Psychiatric and 
medical patients  
18 years and older 
1.29 
(1.03 – 1.62) 
1.24 
(1.01 – 1.52) 
1.13 
(0.97 – 1.32) 
O’Neill33
N = 20 
American aboriginals 
29 – 79 years 
3.00 
(0.39 – 24.1) 
2.00 
(0.18 – 14.0) 
1.67 
(0.20 – 6.02) 
NLAES34
N = 42862 
Population sample  
18 years and older 
3.65 
(3.19 – 4.16) 
3.08 
(2.73 – 3.47) 
2.88 
(2.56 – 3.22) 
 
 
As expected, cluster coefficients are nearer to unity than odds ratios in all, with 
risk ratios taking an intermediate position. However, the strength of the 
association, whichever statistic is used to express it, varies considerably between 
studies. A sizeable proportion of this heterogeneity is attributable to between-
study variation in the prevalence of the two separate conditions – associations are 




























































































It is well known that, like somatic disorders, mental disorders are not distributed 
at random across populations but cluster in a minority.9 Several mechanisms may 
contribute to this. First and foremost, in psychiatry more than in somatic 
medicine, different clinical manifestations of one disorder may, mistakenly, have 
been classified as if they were separate disorders.4,21 Thus, it is debatable whether 
major depression and generalized anxiety disorder are two different entities or 
clinical variations of one underlying condition.22 Secondly, psychiatric disorders 
may act as risk factors for one another and this may partly explain why substance 
use co-occurs so often with anxiety and affective disorders.23 Thirdly, in chronic 
disease medicine symptom diversity (i.e. comorbidity or (better) multimorbidity) 
is increasingly seen as an indicator of severity of illness alongside symptom 
chronicity and intensity. Thus, comorbidity indices have been developed which 
weigh overall severity of illness according to the number of individual conditions 
and their seriousness.24 The cluster or multimorbidity coefficient discussed in this 
paper is an example of this approach. It is efficient in identifying the extent to 
which illness concentrates in a sick minority, but, as a pay-off, less effective in 
identifying which combinations of disorders tend to co-occur most often, a 
particular interest of nosologists. 
If the focus of interest is on the etiology of comorbidity rather than its 
nosological implications, it is important that a clear separation be made between 
coincidental and cluster comorbidity. As a statistical necessity, comorbidity rates 
are higher in populations with higher base rates of illness. The implications of this 
deserve more attention. For instance, it is unclear whether the relatively high 
prevalence of psychiatric multimorbidity in young adulthood compared to other 
ages6 is in excess of what is to be expected merely on the basis of the fact that the 
prevalence of psychiatric disorder is in any case at its highest in this group. 
Adjusting observed comorbidity rates for what can be expected, i.e. calculating 
the multimorbidity coefficient, would provide the answer. 
Adjustment of comorbidity rates for what can be expected will remove 
some, but not all, of the variation between studies of comorbidity conducted in 




coincidental comorbidity, a statistical artifact but, rather, representative of a 
phenomenon of substantive interest. Evidence is accumulating to suggest that the 
strength of risk-outcome associations in psychiatric epidemiology tends to 
diminish as exposure to the risk factors in question becomes more widespread.20 
This applies not only to risk factors like ethnic minority status25 and 
unemployment26, but also to problems like cocaine18 or alcohol misuse27. A 
variety of mechanisms may explain this dilution or concentration of risk20 by 
overall morbidity levels. The impact of exposure (for instance, to given levels of 
alcohol consumption) and, thus, the risk of complications like comorbid 
depression is less when the exposure is more prevalent (i.e. drinking more 
normative) – an example of social causation. On the other hand, it requires higher 
levels of vulnerability (and, thus, high risk of comorbidity) to develop a condition 





Comorbidity can be studied not only as a feature of disorders but also as a feature 
of individuals. When the focus is on the latter, measures of clustering – little used 
in psychiatry – are more appropriate than measures of association as the latter are, 
of necessity, stronger in groups with more disorders like, in psychiatry, the young. 
Between-study variation that remains after coincidental comorbidity has been 
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